{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:04:38Z","timestamp":1792461878034,"version":"4.5.0"},"reference-count":157,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1385,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Mutat."],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1002\/humu.21636","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T10:32:44Z","timestamp":1320143564000},"page":"29-41","source":"Crossref","is-referenced-by-count":188,"title":["Sixteen years and counting: The current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias"],"prefix":"10.1155","volume":"33","author":[{"given":"Silvie","family":"Foldynova-Trantirkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Krejci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,11,16]]},"reference":[{"key":"10.1002\/humu.21636-BIB1|cit1","doi-asserted-by":"crossref","first-page":"29347","DOI":"10.1074\/jbc.M101859200","article-title":"Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2","volume":"276","author":"Aikawa","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21636-BIB2|cit2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1389450033490993","article-title":"Fibroblast growth factor receptor-3 as a therapeutic target for achondroplasia-genetic short limbed dwarfism","volume":"4","author":"Aviezer","year":"2003","journal-title":"Curr Drug Targets"},{"key":"10.1002\/humu.21636-BIB3|cit3","first-page":"1089","article-title":"Flg-2, a new member of the family of fibroblast growth factor receptors","volume":"6","author":"Avivi","year":"1991","journal-title":"Oncogene"},{"key":"10.1002\/humu.21636-BIB4|cit4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/422013","article-title":"Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux","volume":"75","author":"Bartels","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.21636-BIB5|cit5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35000034","article-title":"The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells","volume":"2","author":"Batlle","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1002\/humu.21636-BIB6|cit6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2007.12.008","article-title":"Achondroplasia","volume":"22","author":"Baujat","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1002\/humu.21636-BIB7|cit7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2052.2005.01398.x","article-title":"A single-base change in the tyrosine kinase II domain of ovine FGFR3 causes hereditary chondrodysplasia in sheep","volume":"37","author":"Beever","year":"2006","journal-title":"Anim Genet"},{"key":"10.1002\/humu.21636-BIB8|cit8","first-page":"368","article-title":"Achondroplasia is defined by recurrent G380R mutations of FGFR3","volume":"56","author":"Bellus","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.21636-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/316892","article-title":"Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype","volume":"67","author":"Bellus","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.21636-BIB10|cit10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1242\/jcs.02740","article-title":"Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling","volume":"119","author":"Ben-Zvi","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1002\/humu.21636-BIB11|cit11","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1111\/j.1742-4658.2007.05835.x","article-title":"The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor","volume":"274","author":"Bonaventure","year":"2007","journal-title":"FEBS J"},{"key":"10.1002\/humu.21636-BIB12|cit12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0968-0004(01)01958-2","article-title":"Ten years of protein kinase B signalling: a hard Akt to follow","volume":"26","author":"Brazil","year":"2001","journal-title":"Trends Biochem Sci"},{"key":"10.1002\/humu.21636-BIB13|cit13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/(SICI)1096-8628(19990611)84:5<476::AID-AJMG12>3.0.CO;2-X","article-title":"Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations","volume":"84","author":"Brodie","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1002\/humu.21636-BIB14|cit14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/(SICI)1096-8628(19981116)80:3<260::AID-AJMG15>3.0.CO;2-S","article-title":"Thanatophoric dysplasia type I with syndactyly","volume":"80","author":"Brodie","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1002\/humu.21636-BIB15|cit15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/12615","article-title":"Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas","volume":"23","author":"Cappellen","year":"1999","journal-title":"Nat Genet"},{"key":"10.1002\/humu.21636-BIB16|cit16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/JME-10-0177","article-title":"Organization of the Indian hedgehog-parathyroid hormone-related protein system in the postnatal growth plate","volume":"47","author":"Chau","year":"2011","journal-title":"J Mol Endocrinol"},{"key":"10.1002\/humu.21636-BIB17|cit17","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1038\/sj.onc.1208989","article-title":"FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies","volume":"24","author":"Chen","year":"2005","journal-title":"Oncogene"},{"key":"10.1002\/humu.21636-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1172\/JCI6690","article-title":"Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis","volume":"104","author":"Chen","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1002\/humu.21636-BIB19|cit19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/hmg\/10.5.457","article-title":"A Ser(365)->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh\/PTHrP signals and causes severe achondroplasia","volume":"10","author":"Chen","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21636-BIB20|cit20","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1002\/art.23985","article-title":"Regulation of articular chondrocyte proliferation and differentiation by indian hedgehog and parathyroid hormone-related protein","volume":"58","author":"Chen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1002\/humu.21636-BIB21|cit21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood.V97.3.729","article-title":"Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma","volume":"97","author":"Chesi","year":"2001","journal-title":"Blood"},{"key":"10.1002\/humu.21636-BIB22|cit22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat Genet"},{"key":"10.1002\/humu.21636-BIB23|cit23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.272.5262.719","article-title":"Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1\/CIP1 mediated by STAT1","volume":"272","author":"Chin","year":"1996","journal-title":"Science"},{"key":"10.1002\/humu.21636-BIB24|cit24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1073\/pnas.2237184100","article-title":"Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia","volume":"101","author":"Cho","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.21636-BIB25|cit25","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1073\/pnas.071389098","article-title":"Dwarfism and early death in mice lacking C-type natriuretic peptide","volume":"98","author":"Chusho","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.21636-BIB26|cit26","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ng0496-390","article-title":"Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3","volume":"12","author":"Colvin","year":"1996","journal-title":"Nat Genet"},{"key":"10.1002\/humu.21636-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0002-9440(10)64409-4","article-title":"Parathyroid hormone receptor type 1\/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations","volume":"161","author":"Cormier","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1002\/humu.21636-BIB28|cit28","first-page":"71","article-title":"Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I","volume":"9","author":"d'Avis","year":"1998","journal-title":"Cell Growth Differ"},{"key":"10.1002\/humu.21636-BIB29|cit29","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1086\/381715","article-title":"Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann\/Schwartz-Jampel type 2 syndrome","volume":"74","author":"Dagoneau","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.21636-BIB30|cit30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cytogfr.2005.01.007","article-title":"Mechanisms underlying differential responses to FGF signaling","volume":"16","author":"Dailey","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1002\/humu.21636-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.200302075","article-title":"A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation","volume":"161","author":"Dailey","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1002\/humu.21636-BIB32|cit32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/edrv-10-1-68","article-title":"Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations","volume":"10","author":"Daughaday","year":"1989","journal-title":"Endocr Rev"},{"key":"10.1002\/humu.21636-BIB33|cit33","first-page":"3077","article-title":"rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice","volume":"62","author":"Davidoff","year":"2002","journal-title":"Cancer Res"},{"key":"10.1002\/humu.21636-BIB34|cit34","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.devcel.2007.09.016","article-title":"Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias","volume":"13","author":"ER> de Frutos","year":"2007","journal-title":"Dev Cell"},{"key":"10.1002\/humu.21636-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/hmg\/6.11.1899","article-title":"Abnormal FGFR 3 expression in cartilage of thanatophoric dysplasia fetuses","volume":"6","author":"Delezoide","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21636-BIB36|cit36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"},{"key":"10.1002\/humu.21636-BIB37|cit37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-8674(00)81289-1","article-title":"Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease","volume":"84","author":"Durbin","year":"1996","journal-title":"Cell"},{"key":"10.1002\/humu.21636-BIB38|cit38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0092-8674(95)90487-5","article-title":"Toward a molecular understanding of skeletal development","volume":"80","author":"Erlebacher","year":"1995","journal-title":"Cell"},{"key":"10.1002\/humu.21636-BIB39|cit39","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.275.5300.665","article-title":"Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate","volume":"275","author":"Franke","year":"1997","journal-title":"Science"},{"key":"10.1002\/humu.21636-BIB40|cit40","first-page":"85","article-title":"Guanylate cyclase receptor family","volume":"46","author":"Garbers","year":"1990","journal-title":"Recent Prog Horm Res"},{"key":"10.1002\/humu.21636-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ng.470","article-title":"Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors","volume":"41","author":"Goriely","year":"2009","journal-title":"Nat Genet"},{"key":"10.1002\/humu.21636-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cellsig.2008.04.001","article-title":"Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: A severe form of human achondroplasia","volume":"20","author":"Guo","year":"2008","journal-title":"Cell Signal"},{"key":"10.1002\/humu.21636-BIB43|cit43","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1128\/MCB.18.7.3966","article-title":"Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation","volume":"18","author":"Hadari","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1002\/humu.21636-BIB44|cit44","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1172\/JCI28163","article-title":"Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi","volume":"116","author":"Hafner","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1002\/humu.21636-BIB45|cit45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1148\/133.1.95","article-title":"Hypochondroplasia: Clinical and radiological aspects in 39 cases","volume":"133","author":"Hall","year":"1979","journal-title":"Radiology"},{"key":"10.1002\/humu.21636-BIB46|cit46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bone.2006.11.030","article-title":"Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCgamma-activated STAT1","volume":"41","author":"Harada","year":"2007","journal-title":"Bone"},{"key":"10.1002\/humu.21636-BIB47|cit47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00774-008-0009-7","article-title":"FGFR3-related dwarfism and cell signaling","volume":"27","author":"Harada","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"10.1002\/humu.21636-BIB48|cit48","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1091\/mbc.12.4.931","article-title":"Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation","volume":"12","author":"Hart","year":"2001","journal-title":"Mol Biol Cell"},{"key":"10.1002\/humu.21636-BIB49|cit49","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/sj.onc.1203650","article-title":"Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4","volume":"19","author":"Hart","year":"2000","journal-title":"Oncogene"},{"key":"10.1002\/humu.21636-BIB50|cit50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1359\/jbmr.2000.15.1.155","article-title":"Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells","volume":"15","author":"Henderson","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1002\/humu.21636-BIB51|cit51","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","article-title":"Achondroplasia","volume":"370","author":"Horton","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/humu.21636-BIB52|cit52","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/MCB.25.2.671-684.2005","article-title":"Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization","volume":"25","author":"Ibrahimi","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1002\/humu.21636-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/hmg\/9.11.1603","article-title":"A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos","volume":"9","author":"Iwata","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21636-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/hmg\/10.12.1255","article-title":"Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice","volume":"10","author":"Iwata","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21636-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(08)60821-0","article-title":"Structural and functional diversity in the FGF receptor multigene family","volume":"60","author":"Johnson","year":"1993","journal-title":"Adv Cancer Res"},{"key":"10.1002\/humu.21636-BIB56|cit56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1101\/gad.8.3.277","article-title":"Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene","volume":"8","author":"Karaplis","year":"1994","journal-title":"Genes Dev"},{"key":"10.1002\/humu.21636-BIB57|cit57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S8756-3282(99)00111-8","article-title":"Cbfa1 as a regulator of osteoblast differentiation and function","volume":"25","author":"Karsenty","year":"1999","journal-title":"Bone"},{"key":"10.1002\/humu.21636-BIB58|cit58","first-page":"362","article-title":"Lys650Met substitution in the tyrosine kinase domain of the fibroblast growth factor receptor gene causes thanatophoric dysplasia Type I. Mutations in brief no. 199. Online","volume":"12","author":"Kitoh","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.21636-BIB59|cit59","doi-asserted-by":"crossref","first-page":"D165","DOI":"10.2741\/Klint","article-title":"Signal transduction by fibroblast growth factor receptors","volume":"4","author":"Klint","year":"1999","journal-title":"Front Biosci"},{"key":"10.1002\/humu.21636-BIB60|cit60","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1359\/jbmr.2003.18.11.2043","article-title":"Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK","volume":"18","author":"Koike","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1002\/humu.21636-BIB61|cit61","doi-asserted-by":"crossref","first-page":"e3447","DOI":"10.1371\/journal.pone.0003447","article-title":"PP2A-mediated dephosphorylation of p107 plays a critical role in chondrocyte cell cycle arrest by FGF","volume":"3","author":"Kolupaeva","year":"2008","journal-title":"PLoS One"},{"key":"10.1002\/humu.21636-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1083\/jcb.102.4.1151","article-title":"Collagen gene expression during limb cartilage differentiation","volume":"102","author":"Kosher","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1002\/humu.21636-BIB63|cit63","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)80252-4","article-title":"A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras\/MAPK signaling pathway","volume":"89","author":"Kouhara","year":"1997","journal-title":"Cell"},{"key":"10.1002\/humu.21636-BIB64|cit64","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.yexcr.2004.03.011","article-title":"FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells","volume":"297","author":"Krejci","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1002\/humu.21636-BIB65|cit65","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1203\/pdr.0b013e318030d157","article-title":"Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage","volume":"61","author":"Krejci","year":"2007a","journal-title":"Pediatr Res"},{"key":"10.1002\/humu.21636-BIB66|cit66","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1242\/jcs.02618","article-title":"Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis","volume":"118","author":"Krejci","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1002\/humu.21636-BIB67|cit67","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1074\/jbc.M606144200","article-title":"Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of ERK MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins","volume":"282","author":"Krejci","year":"2007b","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21636-BIB68|cit68","doi-asserted-by":"crossref","first-page":"20644","DOI":"10.1074\/jbc.M109.083626","article-title":"NF449 is a novel inhibitor of fibroblast growth factor receptor 3 (FGFR3) signaling active in chondrocytes and multiple myeloma cells","volume":"285","author":"Krejci","year":"2010a","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21636-BIB69|cit69","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10637-007-9054-7","article-title":"Simple, mammalian cell-based assay for identification of inhibitors of the ERK MAP kinase pathway","volume":"25","author":"Krejci","year":"2007c","journal-title":"Invest New Drugs"},{"key":"10.1002\/humu.21636-BIB70|cit70","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cellsig.2008.10.006","article-title":"Fibroblast growth factor inhibits interferon gamma-STAT1 and interleukin 6-STAT3 signaling in chondrocytes","volume":"21","author":"Krejci","year":"2009","journal-title":"Cell Signal"},{"key":"10.1002\/humu.21636-BIB71|cit71","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bone.2010.03.021","article-title":"FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence","volume":"47","author":"Krejci","year":"2010b","journal-title":"Bone"},{"key":"10.1002\/humu.21636-BIB72|cit72","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1242\/jcs.017160","article-title":"STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes","volume":"121","author":"Krejci","year":"2008a","journal-title":"J Cell Sci"},{"key":"10.1002\/humu.21636-BIB73|cit73","doi-asserted-by":"crossref","first-page":"e3961","DOI":"10.1371\/journal.pone.0003961","article-title":"Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage","volume":"3","author":"Krejci","year":"2008b","journal-title":"PLoS One"},{"key":"10.1002\/humu.21636-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1346.002","article-title":"PTHrP and skeletal development","volume":"1068","author":"Kronenberg","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1002\/humu.21636-BIB75|cit75","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.yexcr.2004.11.012","article-title":"Cell responses to FGFR3 signalling: growth, differentiation and apoptosis","volume":"304","author":"L'Hote","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1002\/humu.21636-BIB76|cit76","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M110.206151","article-title":"Fibroblast growth factor receptor 3 (FGFR3) is a strong heat shock protein 90 (Hsp90) client: Implications for therapeutic manipulation","author":"Laederich","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21636-BIB77|cit77","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1126\/science.273.5275.663","article-title":"PTH\/PTHrP receptor in early development and Indian hedgehog-regulated bone growth","volume":"273","author":"Lanske","year":"1996","journal-title":"Science"},{"key":"10.1002\/humu.21636-BIB78|cit78","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1097-2765(02)00689-5","article-title":"The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors","volume":"10","author":"Lax","year":"2002","journal-title":"Mol Cell"},{"key":"10.1002\/humu.21636-BIB79|cit79","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.1074\/jbc.273.21.13007","article-title":"Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia","volume":"273","author":"Legeai-Mallet","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21636-BIB80|cit80","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bone.2003.09.002","article-title":"Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias","volume":"34","author":"Legeai-Mallet","year":"2004","journal-title":"Bone"},{"key":"10.1002\/humu.21636-BIB81|cit81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/8.1.35","article-title":"A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors","volume":"8","author":"Li","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21636-BIB82|cit82","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood.V97.8.2413","article-title":"The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells","volume":"97","author":"Li","year":"2001","journal-title":"Blood"},{"key":"10.1002\/humu.21636-BIB83|cit83","doi-asserted-by":"crossref","first-page":"17344","DOI":"10.1074\/jbc.M212710200","article-title":"The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum","volume":"278","author":"Lievens","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21636-BIB84|cit84","doi-asserted-by":"crossref","first-page":"43254","DOI":"10.1074\/jbc.M405247200","article-title":"The kinase activity of fibroblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling","volume":"279","author":"Lievens","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21636-BIB85|cit85","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jmb.2006.01.058","article-title":"K644E\/M FGFR3 mutants activate ERK1\/2 from the endoplasmic reticulum through FRS2 alpha and PLC gamma-independent pathways","volume":"357","author":"Lievens","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1002\/humu.21636-BIB86|cit86","first-page":"59","article-title":"Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)","volume":"75","author":"Liu","year":"1993","journal-title":"Cell"},{"key":"10.1002\/humu.21636-BIB87|cit87","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.965602","article-title":"Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18","volume":"16","author":"Liu","year":"2002","journal-title":"Genes Dev"},{"key":"10.1002\/humu.21636-BIB88|cit88","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1242\/dev.128.24.5099","article-title":"Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation","volume":"128","author":"Long","year":"2001","journal-title":"Development"},{"key":"10.1002\/humu.21636-BIB89|cit89","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/hmg\/ddi127","article-title":"Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans","volume":"14","author":"Logie","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21636-BIB90|cit90","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/jcp.21342","article-title":"Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair","volume":"215","author":"Macsai","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1002\/humu.21636-BIB91|cit91","first-page":"2519","article-title":"[Thanatophoric dwarfism]","volume":"75","author":"Maroteaux","year":"1967","journal-title":"Presse Med"},{"key":"10.1002\/humu.21636-BIB92|cit92","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ajmg.a.33188","article-title":"Review of the recently defined molecular mechanisms underlying thanatophoric dysplasia and their potential therapeutic implications for achondroplasia","volume":"152A","author":"Martinez-Frias","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1002\/humu.21636-BIB93|cit93","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/hmg\/ddn339","article-title":"FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway","volume":"18","author":"Matsushita","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21636-BIB94|cit94","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1158\/0008-5472.CAN-08-0575","article-title":"Nordihydroguaiaretic acid inhibits an activated fibroblast growth factor receptor 3 mutant and blocks downstream signaling in multiple myeloma cells","volume":"68","author":"Meyer","year":"2008","journal-title":"Cancer Res"},{"key":"10.1002\/humu.21636-BIB95|cit95","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1093\/emboj\/17.20.5896","article-title":"Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain","volume":"17","author":"Mohammadi","year":"1998","journal-title":"EMBO J"},{"key":"10.1002\/humu.21636-BIB96|cit96","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1126\/science.276.5314.955","article-title":"Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors","volume":"276","author":"Mohammadi","year":"1997","journal-title":"Science"},{"key":"10.1002\/humu.21636-BIB97|cit97","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/MCB.20.2.516-522.2000","article-title":"The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation","volume":"20","author":"Monsonego-Ornan","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1002\/humu.21636-BIB98|cit98","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-5793(02)03255-6","article-title":"FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation","volume":"528","author":"Monsonego-Ornan","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1002\/humu.21636-BIB99|cit99","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gad.1179104","article-title":"Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype","volume":"18","author":"Murakami","year":"2004","journal-title":"Genes Dev"},{"key":"10.1002\/humu.21636-BIB100|cit100","first-page":"907","article-title":"Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides","volume":"10","author":"Nakao","year":"1992","journal-title":"J Hypertens"},{"key":"10.1002\/humu.21636-BIB101|cit101","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1158\/1078-0432.CCR-09-3112","article-title":"New molecular and biological mechanism of antitumor activities of KW-2478, a novel nonansamycin heat shock protein 90 inhibitor, in multiple myeloma cells","volume":"16","author":"Nakashima","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1002\/humu.21636-BIB102|cit102","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","article-title":"Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3","volume":"125","author":"Naski","year":"1998","journal-title":"Development"},{"key":"10.1002\/humu.21636-BIB103|cit103","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"Naski","year":"1996","journal-title":"Nat Genet"},{"key":"10.1002\/humu.21636-BIB104|cit104","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/hmg\/ddi161","article-title":"Sustained ERK1\/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells","volume":"14","author":"Nowroozi","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21636-BIB105|cit105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/jmg.16.2.140","article-title":"Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine","volume":"16","author":"Oberklaid","year":"1979","journal-title":"J Med Genet"},{"key":"10.1002\/humu.21636-BIB106|cit106","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1073\/pnas.111114298","article-title":"Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins","volume":"98","author":"Ong","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.21636-BIB107|cit107","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2005.02.003","article-title":"FGF signaling in the developing endochondral skeleton","volume":"16","author":"Ornitz","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1002\/humu.21636-BIB108|cit108","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2","article-title":"Clinical spectrum of fibroblast growth factor receptor mutations","volume":"14","author":"Passos-Bueno","year":"1999","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.21636-BIB109|cit109","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ymgme.2007.06.014","article-title":"C-natriuretic peptide: an important regulator of cartilage","volume":"92","author":"Pejchalova","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1002\/humu.21636-BIB110|cit110","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1101\/gad.1089403","article-title":"Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2","volume":"17","author":"Peng","year":"2003","journal-title":"Genes Dev"},{"key":"10.1002\/humu.21636-BIB111|cit111","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/dbio.1993.1040","article-title":"Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis","volume":"155","author":"Peters","year":"1993","journal-title":"Dev Biol"},{"key":"10.1002\/humu.21636-BIB112|cit112","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1126\/science.274.5295.2082","article-title":"Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II","volume":"274","author":"Pfeifer","year":"1996","journal-title":"Science"},{"key":"10.1002\/humu.21636-BIB113|cit113","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1182\/blood.V95.3.992.003k29_992_998","article-title":"Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis","volume":"95","author":"Plowright","year":"2000","journal-title":"Blood"},{"key":"10.1002\/humu.21636-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0070-2153(06)76001-X","article-title":"BMP signaling in the cartilage growth plate","volume":"76","author":"Pogue","year":"2006","journal-title":"Curr Top Dev Biol"},{"key":"10.1002\/humu.21636-BIB115|cit115","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/hmg\/4.11.2097","article-title":"A common FGFR3 gene mutation in hypochondroplasia","volume":"4","author":"Prinos","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21636-BIB116|cit116","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/jcp.20620","article-title":"Downregulation of Akt activity contributes to the growth arrest induced by FGF in chondrocytes","volume":"207","author":"Priore","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1002\/humu.21636-BIB117|cit117","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1172\/JCI38017","article-title":"Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice","volume":"119","author":"Qing","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1002\/humu.21636-BIB118|cit118","doi-asserted-by":"crossref","first-page":"35250","DOI":"10.1074\/jbc.273.52.35250","article-title":"Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation","volume":"273","author":"Raffioni","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21636-BIB119|cit119","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1074\/jbc.M310384200","article-title":"Activation of the ERK1\/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes","volume":"279","author":"Raucci","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21636-BIB120|cit120","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/sj.onc.1204465","article-title":"Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): Comparative analysis of Y373C, K650E and the novel G384D mutations","volume":"20","author":"Ronchetti","year":"2001","journal-title":"Oncogene"},{"key":"10.1002\/humu.21636-BIB121|cit121","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/1521-1878(200009)22:9<818::AID-BIES7>3.0.CO;2-6","article-title":"Integrating the MAP kinase signal into the G1 phase cell cycle machinery","volume":"22","author":"Roovers","year":"2000","journal-title":"Bioessays"},{"key":"10.1002\/humu.21636-BIB122|cit122","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"key":"10.1002\/humu.21636-BIB123|cit123","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jmg.33.9.749","article-title":"Clinical and genetic heterogeneity of hypochondroplasia","volume":"33","author":"Rousseau","year":"1996","journal-title":"J Med Genet"},{"key":"10.1002\/humu.21636-BIB124|cit124","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ng0595-11","article-title":"Stop codon FGFR3 mutations in thanatophoric dwarfism type 1","volume":"10","author":"Rousseau","year":"1995","journal-title":"Nat Genet"},{"key":"10.1002\/humu.21636-BIB125|cit125","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1101\/gad.13.11.1361","article-title":"FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway","volume":"13","author":"Sahni","year":"1999","journal-title":"Genes Dev"},{"key":"10.1002\/humu.21636-BIB126|cit126","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1242\/dev.128.11.2119","article-title":"STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2","volume":"128","author":"Sahni","year":"2001","journal-title":"Development"},{"key":"10.1002\/humu.21636-BIB127|cit127","first-page":"pe40","article-title":"The Cbl family: ubiquitin ligases regulating signaling by tyrosine kinases","author":"Sanjay","year":"2001","journal-title":"Sci STKE"},{"key":"10.1002\/humu.21636-BIB128|cit128","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/leu.2010.289","article-title":"The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival","volume":"25","author":"Scuto","year":"2011","journal-title":"Leukemia"},{"key":"10.1002\/humu.21636-BIB129|cit129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jor.21262","article-title":"Genetic inactivation of ERK1 and ERK2 in chondrocytes promotes bone growth and enlarges the spinal canal","volume":"29","author":"Sebastian","year":"2011","journal-title":"J Orthop Res"},{"key":"10.1002\/humu.21636-BIB130|cit130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/hmg\/9.2.249","article-title":"Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice","volume":"9","author":"Segev","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21636-BIB131|cit131","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell"},{"key":"10.1002\/humu.21636-BIB132|cit132","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI19872","article-title":"Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways","volume":"113","author":"Sims","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1002\/humu.21636-BIB133|cit133","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/386288a0","article-title":"Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism","volume":"386","author":"Su","year":"1997","journal-title":"Nature"},{"key":"10.1002\/humu.21636-BIB134|cit134","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1128\/MCB.18.12.6983","article-title":"Cyclic-GMP-dependent protein kinase inhibits the Ras\/Mitogen-activated protein kinase pathway","volume":"18","author":"Suhasini","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1002\/humu.21636-BIB135|cit135","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/302275","article-title":"A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene","volume":"64","author":"Tavormina","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.21636-BIB136|cit136","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat Genet"},{"key":"10.1002\/humu.21636-BIB137|cit137","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1086\/508433","article-title":"A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome","volume":"79","author":"Toydemir","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.21636-BIB138|cit138","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1182\/blood-2004-10-3913","article-title":"CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma","volume":"105","author":"Trudel","year":"2005","journal-title":"Blood"},{"key":"10.1002\/humu.21636-BIB139|cit139","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1182\/blood-2005-10-4179","article-title":"The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells","volume":"107","author":"Trudel","year":"2006","journal-title":"Blood"},{"key":"10.1002\/humu.21636-BIB140|cit140","doi-asserted-by":"crossref","first-page":"14288","DOI":"10.1074\/jbc.C500024200","article-title":"A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn\/cn mouse","volume":"280","author":"Tsuji","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21636-BIB141|cit141","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bone.2007.02.028","article-title":"PTH has the potential to rescue disturbed bone growth in achondroplasia","volume":"41","author":"Ueda","year":"2007","journal-title":"Bone"},{"key":"10.1002\/humu.21636-BIB142|cit142","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1126\/science.273.5275.613","article-title":"Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein","volume":"273","author":"Vortkamp","year":"1996","journal-title":"Science"},{"key":"10.1002\/humu.21636-BIB143|cit143","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/ajmg.a.32485","article-title":"The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US","volume":"146A","author":"Waller","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1002\/humu.21636-BIB144|cit144","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1128\/MCB.16.8.4081","article-title":"Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II","volume":"16","author":"Webster","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1002\/humu.21636-BIB145|cit145","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/j.1460-2075.1996.tb00384.x","article-title":"Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia","volume":"15","author":"Webster","year":"1996","journal-title":"EMBO J"},{"key":"10.1002\/humu.21636-BIB146|cit146","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.matbio.2005.07.003","article-title":"FGF upregulates osteopontin in epiphyseal growth plate chondrocytes: Implications for endochondral ossification","volume":"24","author":"Weizmann","year":"2005","journal-title":"Matrix Biol"},{"key":"10.1002\/humu.21636-BIB147|cit147","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/(SICI)1096-8628(19980707)78:3<274::AID-AJMG14>3.0.CO;2-C","article-title":"Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia","volume":"78","author":"Wilcox","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1002\/humu.21636-BIB148|cit148","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1073\/pnas.052138899","article-title":"FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl","volume":"99","author":"Wong","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.21636-BIB149|cit149","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1158\/1078-0432.CCR-06-0957","article-title":"CHIR-258 is efficacious in a newly developed fibroblast growth factor receptor 3-expressing orthotopic multiple myeloma model in mice","volume":"12","author":"Xin","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1002\/humu.21636-BIB150|cit150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2004.11.051","article-title":"Shisa promotes head formation through the inhibition of receptor protein maturation for the caudalizing factors, Wnt and FGF","volume":"120","author":"Yamamoto","year":"2005","journal-title":"Cell"},{"key":"10.1002\/humu.21636-BIB151|cit151","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1359\/jbmr.2003.18.8.1395","article-title":"PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation","volume":"18","author":"Yamanaka","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1002\/humu.21636-BIB152|cit152","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","article-title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway","volume":"10","author":"Yasoda","year":"2004","journal-title":"Nat Med"},{"key":"10.1002\/humu.21636-BIB153|cit153","doi-asserted-by":"crossref","first-page":"19382","DOI":"10.1074\/jbc.M200732200","article-title":"ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase","volume":"277","author":"Yu","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21636-BIB154|cit154","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1242\/dev.01053","article-title":"VEGFA is necessary for chondrocyte survival during bone development","volume":"131","author":"Zelzer","year":"2004","journal-title":"Development"},{"key":"10.1002\/humu.21636-BIB155|cit155","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1074\/jbc.M601252200","article-title":"Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family","volume":"281","author":"Zhang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21636-BIB156|cit156","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/gt.2010.133","article-title":"Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection","volume":"18","author":"Zhang","year":"2011","journal-title":"Gene Ther"},{"key":"10.1002\/humu.21636-BIB157|cit157","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1158\/1535-7163.MCT-04-0330","article-title":"Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma","volume":"4","author":"Zhu","year":"2005","journal-title":"Mol Cancer Ther"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.21636","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/humu.21636\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T11:52:46Z","timestamp":1672314766000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.21636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,16]]},"references-count":157,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"URL":"https:\/\/doi.org\/10.1002\/humu.21636","relation":{},"ISSN":["1059-7794"],"issn-type":[{"value":"1059-7794","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11,16]]}}}